Ten years ago, Steve Jobs predicted a future where revolutionary innovations would emerge from the intersection of biology and technology. Today, this vision is taking shape as advances in biotechnology reshape industries worldwide. From healthcare to agriculture to energy, the modern biorevolution draws on centuries of human ingenuity to harness nature to produce goods and services.
The convergence of science and business in the 1970s stimulated the birth of biotech companies, boosting research and development efforts. Revolutionary devices such as DNA sequencers have accelerated progress, transforming biology into a data-driven computational discipline. Today, the biotech sector is highly attractive for investment, with companies populating stock markets and start-ups flourishing.
The COVID-19 pandemic has further underlined the importance of healthcare solutions, attracting the attention of major economies. Investors see significant earnings potential in biotech, but navigating this dynamic landscape requires diversification and specialist knowledge. As humanity faces urgent global challenges, the convergence of biology and technology offers promising avenues for innovation and sustainability. Read the full article here.
